Mebamamide A
| Internal ID | 5410f623-7d2c-4fd9-8630-c1f7505bc86d |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Depsipeptides > Cyclic depsipeptides |
| IUPAC Name | [(3S,8R)-10-[[(2R)-1-[[(2S)-1-[(2S)-2-[[(2R)-1-[[(3R,6S,7R,10S,13R,16S)-3-benzyl-7-methyl-13-(2-methylpropyl)-2,5,9,12,15-pentaoxo-10-propan-2-yl-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]amino]-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-8-hydroxy-2-methyl-10-oxodecan-3-yl] acetate |
| SMILES (Canonical) | CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)O1)C(C)C)CC(C)C)CC3=CC=CC=C3)NC(=O)C(C)NC(=O)C4CCCN4C(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)CC(CCCCC(C(C)C)OC(=O)C)O |
| SMILES (Isomeric) | C[C@@H]1[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](C(=O)N[C@H](C(=O)O1)C(C)C)CC(C)C)CC3=CC=CC=C3)NC(=O)[C@@H](C)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CC(C)C)NC(=O)[C@@H](CO)NC(=O)C[C@@H](CCCC[C@@H](C(C)C)OC(=O)C)O |
| InChI | InChI=1S/C59H93N9O15/c1-32(2)27-41-52(74)65-49(35(7)8)59(81)82-37(10)50(56(78)64-43(29-39-19-13-12-14-20-39)58(80)68-26-18-23-46(68)55(77)62-41)66-51(73)36(9)60-54(76)45-22-17-25-67(45)57(79)42(28-33(3)4)63-53(75)44(31-69)61-48(72)30-40(71)21-15-16-24-47(34(5)6)83-38(11)70/h12-14,19-20,32-37,40-47,49-50,69,71H,15-18,21-31H2,1-11H3,(H,60,76)(H,61,72)(H,62,77)(H,63,75)(H,64,78)(H,65,74)(H,66,73)/t36-,37-,40-,41-,42+,43-,44-,45+,46+,47+,49+,50+/m1/s1 |
| InChI Key | SNUSGYYFKHRIQF-PTYJSHCWSA-N |
| Popularity | 1 reference in papers |
| Molecular Formula | C59H93N9O15 |
| Molecular Weight | 1168.40 g/mol |
| Exact Mass | 1167.67911329 g/mol |
| Topological Polar Surface Area (TPSA) | 337.00 Ų |
| XlogP | 4.50 |
| Atomic LogP (AlogP) | 1.21 |
| H-Bond Acceptor | 15 |
| H-Bond Donor | 9 |
| Rotatable Bonds | 25 |
| RefChem:925410 |
| ((3S,8R)-10-(((2R)-1-(((2S)-1-((2S)-2-(((2R)-1-(((3R,6S,7R,10S,13R,16S)-3-benzyl-7-methyl-13-(2-methylpropyl)-2,5,9,12,15-pentaoxo-10-propan-2-yl-8-oxa-1,4,11,14-tetrazabicyclo(14.3.0)nonadecan-6-yl)amino)-1-oxopropan-2-yl)carbamoyl)pyrrolidin-1-yl)-4-methyl-1-oxopentan-2-yl)amino)-3-hydroxy-1-oxopropan-2-yl)amino)-8-hydroxy-2-methyl-10-oxodecan-3-yl) acetate |
| CHEMBL3581385 |
| SCHEMBL31593392 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.5404 | 54.04% |
| Caco-2 | - | 0.8653 | 86.53% |
| Blood Brain Barrier | - | 0.9000 | 90.00% |
| Human oral bioavailability | - | 0.7286 | 72.86% |
| Subcellular localzation | Lysosomes | 0.5752 | 57.52% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8242 | 82.42% |
| OATP1B3 inhibitior | + | 0.9184 | 91.84% |
| MATE1 inhibitior | - | 0.8212 | 82.12% |
| OCT2 inhibitior | - | 1.0000 | 100.00% |
| BSEP inhibitior | + | 0.9867 | 98.67% |
| P-glycoprotein inhibitior | + | 0.7431 | 74.31% |
| P-glycoprotein substrate | + | 0.8818 | 88.18% |
| CYP3A4 substrate | + | 0.7552 | 75.52% |
| CYP2C9 substrate | - | 0.7778 | 77.78% |
| CYP2D6 substrate | - | 0.8305 | 83.05% |
| CYP3A4 inhibition | - | 0.8494 | 84.94% |
| CYP2C9 inhibition | - | 0.8996 | 89.96% |
| CYP2C19 inhibition | - | 0.8994 | 89.94% |
| CYP2D6 inhibition | - | 0.9185 | 91.85% |
| CYP1A2 inhibition | - | 0.9663 | 96.63% |
| CYP2C8 inhibition | + | 0.7678 | 76.78% |
| CYP inhibitory promiscuity | - | 0.9429 | 94.29% |
| UGT catelyzed | - | 0.5000 | 50.00% |
| Carcinogenicity (binary) | - | 0.8600 | 86.00% |
| Carcinogenicity (trinary) | Non-required | 0.6486 | 64.86% |
| Eye corrosion | - | 0.9895 | 98.95% |
| Eye irritation | - | 0.8969 | 89.69% |
| Skin irritation | - | 0.7820 | 78.20% |
| Skin corrosion | - | 0.9341 | 93.41% |
| Ames mutagenesis | - | 0.7200 | 72.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7378 | 73.78% |
| Micronuclear | + | 0.8200 | 82.00% |
| Hepatotoxicity | - | 0.5464 | 54.64% |
| skin sensitisation | - | 0.8880 | 88.80% |
| Respiratory toxicity | + | 0.8444 | 84.44% |
| Reproductive toxicity | + | 0.9333 | 93.33% |
| Mitochondrial toxicity | + | 0.9250 | 92.50% |
| Nephrotoxicity | + | 0.7130 | 71.30% |
| Acute Oral Toxicity (c) | III | 0.5945 | 59.45% |
| Estrogen receptor binding | + | 0.7206 | 72.06% |
| Androgen receptor binding | + | 0.7273 | 72.73% |
| Thyroid receptor binding | + | 0.6208 | 62.08% |
| Glucocorticoid receptor binding | + | 0.7178 | 71.78% |
| Aromatase binding | + | 0.7139 | 71.39% |
| PPAR gamma | + | 0.7974 | 79.74% |
| Honey bee toxicity | - | 0.6433 | 64.33% |
| Biodegradation | - | 0.8250 | 82.50% |
| Crustacea aquatic toxicity | + | 0.5600 | 56.00% |
| Fish aquatic toxicity | + | 0.8631 | 86.31% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.99% | 98.95% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.67% | 96.61% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.41% | 96.09% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 98.35% | 97.64% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 98.33% | 96.31% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 97.83% | 91.11% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 97.22% | 92.12% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 97.17% | 98.33% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 96.92% | 94.66% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 96.42% | 97.14% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 95.56% | 99.17% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 95.47% | 82.38% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 95.36% | 88.42% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 95.28% | 95.89% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 95.22% | 93.56% |
| CHEMBL4801 | P29466 | Caspase-1 | 95.16% | 96.85% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 94.99% | 90.08% |
| CHEMBL3524 | P56524 | Histone deacetylase 4 | 94.03% | 92.97% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 93.79% | 95.56% |
| CHEMBL204 | P00734 | Thrombin | 93.59% | 96.01% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 92.94% | 97.09% |
| CHEMBL4198 | P98170 | Inhibitor of apoptosis protein 3 | 91.61% | 97.79% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 91.36% | 85.14% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 91.08% | 96.47% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 90.92% | 100.00% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 88.99% | 82.69% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 88.82% | 95.00% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 88.36% | 97.50% |
| CHEMBL5966 | P55899 | IgG receptor FcRn large subunit p51 | 88.10% | 90.93% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 88.09% | 94.45% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 88.07% | 93.00% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 87.72% | 90.71% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 87.35% | 89.00% |
| CHEMBL3468 | P55210 | Caspase-7 | 87.32% | 95.68% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 86.11% | 98.24% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 85.85% | 95.89% |
| CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 85.84% | 100.00% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 84.39% | 91.19% |
| CHEMBL5028 | O14672 | ADAM10 | 84.32% | 97.50% |
| CHEMBL283 | P08254 | Matrix metalloproteinase 3 | 84.25% | 97.29% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 84.18% | 100.00% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 83.46% | 98.05% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 83.11% | 97.43% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 82.55% | 96.90% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 81.73% | 93.03% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 81.71% | 100.00% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 81.18% | 96.03% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 80.11% | 90.20% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 122178814 |
| LOTUS | LTS0226284 |
| wikiData | Q105256694 |